Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 8Endocrine 1

Conditions

Neuroendocrine Tumors 12Carcinoma, Neuroendocrine 8Carcinoma, Non-Small-Cell Lung 4Adrenocortical Carcinoma 4Thyroid Neoplasms 3Lung Neoplasms 3Carcinoid Tumor 3Vulvar Neoplasms 2Triple Negative Breast Neoplasms 2Thyroid Carcinoma, Anaplastic 2Thyroid Cancer, Papillary 2Small Cell Lung Carcinoma 2Sarcoma 2Pheochromocytoma 2Penile Neoplasms 2Parathyroid Neoplasms 2Paraganglioma 2Ovarian Neoplasms 2Osteosarcoma 2Neurofibrosarcoma 2Mesothelioma 2Melanoma 2Hemangiosarcoma 2Gastro-enteropancreatic neuroendocrine tumor 2Gallbladder Neoplasms 2Cholangiocarcinoma 2Carcinosarcoma 2Carcinoma, Renal Cell 2Carcinoma, Adenoid Cystic 2Adrenal Gland Neoplasms 2

Interventions

milademetan 1fludarabine phosphate 1Specimen Handling 1Radiosurgery 1Nivolumab 1Magnetic Resonance Spectroscopy 1Interleukin-13 1Fluorodeoxyglucose F18 1Cyclophosphamide 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma of Lung × Nivolumab × Endocrine × Clear all
NCT03110978 2026-04-16

Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
140 enrolled
EndocrineThoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡